This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Ming Zhou in Cancer Treatment
Introduction
Ming Zhou is a notable inventor based in Pennington, NJ (US), recognized for his significant contributions to cancer treatment. With a focus on innovative therapies, he has developed methods that enhance the effectiveness of cancer treatments.
Latest Patents
Ming Zhou holds a patent for a groundbreaking method titled "Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancer." This patent outlines methods for the clinical treatment of tumors, particularly advanced solid tumors, in patients with specific levels of serum IL-8. The combination of an anti-IL-8 antibody with an anti-PD-1 antibody represents a promising approach to improving patient outcomes.
Career Highlights
Ming Zhou has made significant strides in the field of oncology through his work at Bristol-Myers Squibb Company. His research and innovations have contributed to the development of effective cancer therapies, showcasing his commitment to advancing medical science.
Collaborations
Ming Zhou has collaborated with esteemed colleagues, including Michael Carleton and David Feltquate, to further enhance the research and development of cancer treatments. Their combined expertise has fostered a collaborative environment that drives innovation.
Conclusion
Ming Zhou's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His patent and collaborations highlight the importance of teamwork in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile